These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28593781)

  • 1. Influence of type 2 diabetes mellitus on Khorana venous thromboembolism risk in colorectal cancer patients.
    Wang R; Liu R; Zhao L; Xu D; Hu L
    Rev Esp Enferm Dig; 2017 Jul; 109(7):503-509. PubMed ID: 28593781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.
    Riedl JM; Posch F; Bezan A; Szkandera J; Smolle MA; Winder T; Rossmann CH; Schaberl-Moser R; Pichler M; Stotz M; Stöger H; Gerger A
    BMC Cancer; 2017 Jun; 17(1):415. PubMed ID: 28619086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy.
    Ramos JD; Casey MF; Bamias A; De Giorgi U; Bellmunt J; Harshman LC; Ladoire S; Wong YN; Alva AS; Rosenberg JE; Galsky MD; Yu EY;
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):755-760. PubMed ID: 27637910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
    Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
    Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predicting the Incidence of Venous Thromboembolism Using the Khorana Score: A Literature Review].
    Nishimura A; Ikeda Y
    Yakugaku Zasshi; 2021; 141(4):611-622. PubMed ID: 33790126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer.
    Li S; Gao P; Qiu J; He X; Mao Y
    J Thromb Thrombolysis; 2021 Oct; 52(3):898-903. PubMed ID: 33599857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer.
    Parker A; Peterson E; Lee AYY; de Wit C; Carrier M; Polley G; Tien J; Wu C
    J Thromb Haemost; 2018 Jul; 16(7):1321-1326. PubMed ID: 29733498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes mellitus associated with increased risk for colorectal cancer: evidence from an international ecological study and population-based risk analysis in China.
    Ren X; Zhang X; Zhang X; Gu W; Chen K; Le Y; Lai M; Zhu Y
    Public Health; 2009 Aug; 123(8):540-4. PubMed ID: 19664792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma.
    Wang Y; Attar BM; Fuentes HE; Yu J; Zhang H; Tafur AJ
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):471-476. PubMed ID: 28288526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.
    Pépin M; Kleinjan A; Hajage D; Büller HR; Di Nisio M; Kamphuisen PW; Salomon L; Veyradier A; Stepanian A; Mahé I
    J Thromb Haemost; 2016 Feb; 14(2):306-15. PubMed ID: 26589836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study.
    Abdel-Razeq H; Sharaf B; Al-Jaghbeer MJ; Abu-Fares H; Bater R; Shaer MA; Abu-Jaish H; Laban DA; Salamah O; Tamimi F; Ashouri K; Salameh T; Zughul R; Alhalaseh Y
    J Thromb Thrombolysis; 2023 Oct; 56(3):447-453. PubMed ID: 37430158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation and risk assessment of venous thromboembolism in gastrointestinal cancers.
    Metcalf RL; Al-Hadithi E; Hopley N; Henry T; Hodgson C; McGurk A; Mansoor W; Hasan J
    World J Gastrointest Oncol; 2017 Sep; 9(9):363-371. PubMed ID: 28979718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer, comorbidity, and risk of venous thromboembolism: assessment of biological interactions in a Danish nationwide cohort.
    Ahern TP; Horváth-Puhó E; Spindler KL; Sørensen HT; Ording AG; Erichsen R
    Br J Cancer; 2016 Jan; 114(1):96-102. PubMed ID: 26625005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer.
    de Kort S; Simons CC; van den Brandt PA; Goldbohm RA; Arts IC; de Bruine AP; Janssen-Heijnen ML; Sanduleanu S; Masclee AA; Weijenberg MP
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):896-903. PubMed ID: 27097356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score.
    Rupa-Matysek J; Gil L; Kaźmierczak M; Barańska M; Komarnicki M
    Med Oncol; 2017 Dec; 35(1):5. PubMed ID: 29209847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PO-03 - Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL).
    Santi RM; Ceccarelli M; Catania G; Monagheddu C; Evangelista A; Bernocco E; Monaco F; Federico M; Vitolo U; Cortelazzo S; Cabras MG; Spina M; Baldini L; Boccomini C; Chiappella A; Bari A; Luminari S; Calabrese M; Levis A; Visco C; Contino L; Ciccone G; Ladetto M
    Thromb Res; 2016 Apr; 140 Suppl 1():S177. PubMed ID: 27161692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients.
    Hiraide M; Shiga T; Minowa Y; Nakano Y; Yoshioka H; Suzuki K; Yasuda C; Takahashi H; Hama T
    J Cardiol; 2020 Jan; 75(1):110-114. PubMed ID: 31416782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.
    Rupa-Matysek J; Lembicz M; Rogowska EK; Gil L; Komarnicki M; Batura-Gabryel H
    Med Oncol; 2018 Apr; 35(5):63. PubMed ID: 29616356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.
    Gerotziafas GT; Taher A; Abdel-Razeq H; AboElnazar E; Spyropoulos AC; El Shemmari S; Larsen AK; Elalamy I;
    Oncologist; 2017 Oct; 22(10):1222-1231. PubMed ID: 28550032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
    Dehal AN; Newton CC; Jacobs EJ; Patel AV; Gapstur SM; Campbell PT
    J Clin Oncol; 2012 Jan; 30(1):53-9. PubMed ID: 22124092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.